Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights

Gabriel I. Barbash, Jonathan Reiner, Harvey D. White, Robert G. Wilcox, Paul W. Armstrong, Zygmunt Sadowsi, Douglas Morris, Philip Aylward, Lynn H. Woodlief, Eric J. Topol, Robert M. Califf, Allan M. Ross

Research output: Contribution to journalArticlepeer-review

210 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: Mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights'. Together they form a unique fingerprint.

Medicine & Life Sciences